MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, NAGE has $106,406K in assets. $29,873K in debts.

Balance Sheets Overview

Current Ratio
486.00%
Quick Ratio
486.00%
Debt to Asset Ratio
28.07%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents, inclu...
    • Trade receivables, net of allowa...
    • Right-of-use assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents, including restricted cash of 152 for both periods presented
64,788
Trade receivables, net of allowances of 147 and 95, respectively
9,741
Inventories
20,424
Assets held for sale
541
Prepaid expenses and other assets
1,312
Total current assets
96,806
Leasehold improvements and equipment, net
1,323
Intangible assets, net
5,660
Right-of-use assets
2,192
Other long-term assets
425
Total assets
106,406
Accounts payable
10,796
Accrued expenses
7,722
Current maturities of operating lease obligations
1,002
Current maturities of finance lease obligations
0
Customer deposits
399
Total current liabilities
19,919
Deferred revenue
2,674
Operating lease obligations, less current maturities
1,815
Deferred consideration liability
5,465
Total liabilities
29,873
Common stock, 0.001 par value authorized 150,000 shares 79,714 shares and 77,330 shares issued and outstanding at december31, 2025 and december31, 2024, respectively
79
Additional paid-in capital
240,991
Accumulated deficit
-164,528
Cumulative translation adjustments
-9
Total stockholders' equity
76,533
Total liabilities and stockholders' equity
106,406
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents, including...$64,788K Inventories$20,424K Trade receivables,net of allowances of...$9,741K Prepaid expenses andother assets$1,312K Assets held for sale$541K Total current assets$96,806K Intangible assets, net$5,660K Right-of-use assets$2,192K Leasehold improvementsand equipment, net$1,323K Other long-termassets$425K Total assets$106,406K Total liabilities andstockholders' equity$106,406K Total stockholders'equity$76,533K Total liabilities$29,873K Accumulated deficit-$164,528K Cumulative translationadjustments-$9K Additional paid-in capital$240,991K Total currentliabilities$19,919K Deferred considerationliability$5,465K Deferred revenue$2,674K Operating leaseobligations, less current...$1,815K Common stock, 0.001 parvalue authorized...$79K Accounts payable$10,796K Accrued expenses$7,722K Current maturities ofoperating lease...$1,002K Customer deposits$399K

Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience, Inc. (NAGE)